Released on: December 19, 2007, 11:08 pm

Press Release Author: Shushmul Maheshwari

Industry: Media

Press Release Summary: India is strengthening its place for conducting clinical
trials for international drug makers, says the RNCOS report. The report has
carefully evaluated the factors working in favor of India.

Press Release Body: Clinical trial is the research study conducted by pharmaceutical
firms to look for more efficient treatment for patients with specific disease. And
in a quest to launch their drug before others, pharmaceutical players are leaving no
stone unturned, from speeding up of the research process to outsourcing the entire
research.

Asia-Pacific is fast emerging as the most promising market for conducting clinical
trials, and among all the Asia-Pacific countries, China and India are likely to
lead, said "Booming Clinical Trials Market in India", the research report by the
leading research firm RNCOS. The report has thoroughly evaluated the factors driving
the market and forecasted that the Indian clinical trails market will grow strongly
at a CAGR of 35.4% during 2006-2011.

Though China has some benefits over India in terms of low cost and better access to
research-related material, a big hitch is that Chinese pharma industry is based on
generics and Traditional Chinese Medicines (TCM), which lacks innovation.
Conversely, India has flourishing pharma companies formulating their own small and
large molecule therapies.

The RNCOS research has looked for the reasons as to why, despite being a novice in
the field, India is being preferred by international drug manufacturers for carrying
out clinical trails. It has traced the cost of conducting clinical trails at global
level in the past and has methodically done a cost (average) and time analysis of
conducting various phases of clinical trials in India with respect to countries like
the US, the UK, and Germany.

The study also talks about the initiatives being taken by the Indian government to
support the clinical trials market in the country. It keeps a watch on the moves and
provisions (like tax incentives and exemptions) made by the Indian government to
rationally dissect the future course of direction of the market.

As put forth by the report, patient recruitment can prove to be a rate-limiting step
in the drug development process. So it has examined the patient concentration per
site and studied the recruitment time for patients participating in clinical trials
in India and the US to give a precise analysis of the Indian market.

The driving forces are just a part of the elaborative "Booming Clinical Trials
Market in India" which focuses on competitive advantages and disadvantages,
opportunities, and challenges for the market.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM564.htm
Current Industry News: http://www.rncos.com/Blog/


Web Site: http://www.rncos.com

Contact Details: RNCOS E-Services Pvt. Ltd.
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
info@rncos.com